Ambalal Sarabhai Enterprises Limited (AMBALALSA.BO)
INR 36.9
(-0.57%)
INR 36.9
(-0.57%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 56.8 Million INR | -50.38% |
| 2022 | 114.47 Million INR | -75.76% |
| 2021 | 472.18 Million INR | 60.85% |
| 2020 | 293.55 Million INR | 108.76% |
| 2019 | 140.61 Million INR | 230.92% |
| 2018 | 42.49 Million INR | 232.72% |
| 2017 | 12.77 Million INR | 107.01% |
| 2016 | -182.26 Million INR | -137.86% |
| 2015 | 481.35 Million INR | 821.6% |
| 2014 | -66.7 Million INR | 66.99% |
| 2013 | -202.07 Million INR | -10.29% |
| 2012 | -183.22 Million INR | 0.0% |
| 2009 | -2.56 Million INR | -103.58% |
| 2008 | 71.49 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 3.47 Million INR | -95.81% |
| 2023 Q2 | 10.83 Million INR | 122.25% |
| 2023 Q3 | 11.79 Million INR | 8.83% |
| 2023 Q4 | 82.88 Million INR | 602.62% |
| 2023 FY | 56.8 Million INR | -50.38% |
| 2023 Q1 | -48.7 Million INR | -188.68% |
| 2022 Q2 | 10.2 Million INR | -35.51% |
| 2022 FY | 114.47 Million INR | -75.76% |
| 2022 Q1 | 15.81 Million INR | -79.15% |
| 2022 Q3 | 30.05 Million INR | 194.63% |
| 2022 Q4 | 54.92 Million INR | 82.74% |
| 2021 Q4 | 75.88 Million INR | 116.9% |
| 2021 Q3 | 34.98 Million INR | -63.31% |
| 2021 FY | 472.18 Million INR | 60.85% |
| 2021 Q2 | 95.34 Million INR | -64.15% |
| 2021 Q1 | 265.96 Million INR | 70.54% |
| 2020 Q4 | 155.95 Million INR | 672.09% |
| 2020 FY | 293.55 Million INR | 108.76% |
| 2020 Q3 | 20.19 Million INR | -81.31% |
| 2020 Q2 | 108.09 Million INR | 1061.68% |
| 2020 Q1 | 9.3 Million INR | -92.79% |
| 2019 Q1 | 5.98 Million INR | -48.84% |
| 2019 FY | 140.61 Million INR | 230.92% |
| 2019 Q3 | 4.62 Million INR | 374.82% |
| 2019 Q4 | 129.13 Million INR | 2695.09% |
| 2019 Q2 | 973 Thousand INR | -83.75% |
| 2018 Q3 | 26.78 Million INR | 1395.76% |
| 2018 Q2 | 1.79 Million INR | -19.65% |
| 2018 Q1 | 2.22 Million INR | -94.42% |
| 2018 Q4 | 11.7 Million INR | -56.32% |
| 2018 FY | 42.49 Million INR | 232.72% |
| 2017 FY | 12.77 Million INR | 107.01% |
| 2017 Q4 | 39.93 Million INR | 42.48% |
| 2017 Q3 | 28.02 Million INR | 205.88% |
| 2017 Q2 | -26.47 Million INR | 7.83% |
| 2017 Q1 | -28.72 Million INR | 0.0% |
| 2016 FY | -182.26 Million INR | -137.86% |
| 2015 FY | 481.35 Million INR | 821.6% |
| 2014 FY | -66.7 Million INR | 66.99% |
| 2013 FY | -202.07 Million INR | -10.29% |
| 2012 FY | -183.22 Million INR | 0.0% |
| 2009 FY | -2.56 Million INR | -103.58% |
| 2008 FY | 71.49 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Add-Shop E-Retail Limited | 31.57 Million INR | -79.934% |
| Cian Healthcare Limited | 2.54 Million INR | -2133.858% |
| Chemo Pharma Laboratories Limited | 12 Million INR | -373.234% |
| Colinz Laboratories Limited | 4.86 Million INR | -1067.187% |
| Denis Chem Lab Limited | 111.55 Million INR | 49.079% |
| Emmessar Biotech & Nutrition Limited | 7.49 Million INR | -657.831% |
| Evoq Remedies Limited | 4.52 Million INR | -1155.681% |
| Gujarat Themis Biosyn Limited | 591.63 Million INR | 90.398% |
| Jenburkt Pharmaceuticals Limited | 259.77 Million INR | 78.132% |
| MedPlus Health Services Limited | 654.73 Million INR | 91.324% |
| OXYGENTA PHARMACEUTICAL LIMITE | -34.79 Million INR | 263.271% |
| PANJON LTD. | 1.51 Million INR | -3651.105% |
| PRAVEG LIMITED | 129.99 Million INR | 56.302% |
| Sanjivani Paranteral Limited. | 61.65 Million INR | 7.858% |
| Sastasundar Ventures Limited | 88.82 Million INR | 36.048% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 14091.872% |
| SHELTER PHARMA LIMITED | 62 Million INR | 8.379% |
| BDH Industries Limited | 98.67 Million INR | 42.432% |
| DECIPHER LABS LIMITED | -16.75 Million INR | 439.025% |
| ANG Lifesciences India Limited | -101.43 Million INR | 156.006% |
| Veerhealth Care Limited | 4.06 Million INR | -1299.187% |
| Zenith Healthcare Limited | 2.03 Million INR | -2691.499% |
| Zenlabs Ethica Limited | 4.21 Million INR | -1248.694% |
| Zenotech Laboratories Limited | 82.98 Million INR | 31.547% |
| Crestchem Limited | 21.46 Million INR | -164.67% |
| Norris Medicines Limited | -11.86 Million INR | 578.677% |
| Shukra Pharmaceuticals Limited | 185.37 Million INR | 69.355% |
| Sunil Healthcare Limited | -17.88 Million INR | 417.624% |
| Bacil Pharma Limited | -590.53 Thousand INR | 9719.664% |
| Fredun Pharmaceuticals Limited | 156.23 Million INR | 63.64% |
| Patidar Buildcon Limited | -956 Thousand INR | 6042.155% |
| Phaarmasia Limited | -5.18 Million INR | 1196.237% |
| Shree Ganesh Remedies Limited | 281.08 Million INR | 79.79% |
| SUDARSHAN PHARMA INDUSTRIES LI | 114.55 Million INR | 50.41% |
| Trimurthi Limited | 104 Thousand INR | -54522.115% |
| Vista Pharmaceuticals Limited | -45.12 Million INR | 225.902% |
| Vivanza Biosciences Limited | 5.47 Million INR | -937.95% |
| Hindustan Bio Sciences Limited | 575.94 Thousand INR | -9763.337% |
| Anuh Pharma Limited | 600.57 Million INR | 90.541% |
| Beryl Drugs Limited | 7.68 Million INR | -639.097% |
| Bharat Immunologicals & Biologicals Corporation Limited | -166.38 Million INR | 134.141% |
| Deccan Health Care Limited | 14.92 Million INR | -280.591% |
| Godavari Drugs Limited | 55.48 Million INR | -2.375% |
| Gujarat Terce Laboratories Limited | 2.43 Million INR | -2233.895% |
| Ishita Drugs and Industries Limited | 7.48 Million INR | -658.945% |
| Kerala Ayurveda Limited | -15.27 Million INR | 471.993% |
| KIMIA BIOSCIENCES LIMITED | -53.08 Million INR | 207.007% |
| Lactose (India) Limited | 67.89 Million INR | 16.325% |
| Makers Laboratories Limited | -62.64 Million INR | 190.687% |
| Medi-Caps Limited | -22.4 Million INR | 353.512% |
| Mercury Laboratories Limited | 56.54 Million INR | -0.469% |
| Parmax Pharma Limited | -1.04 Million INR | 5558.642% |
| Roopa Industries Limited | 15.19 Million INR | -273.952% |
| Smruthi Organics Limited | 35.9 Million INR | -58.224% |
| Source Natural Foods and Herbal Supplements Limited | 17.36 Million INR | -227.135% |
| Syschem (India) Limited | 27.61 Million INR | -105.718% |
| Vikram Thermo (India) Limited | 253.78 Million INR | 77.616% |
| Bharat Parenterals Limited | 145.17 Million INR | 60.869% |
| Trident Lifeline Limited | 63.43 Million INR | 10.454% |
| Concord Drugs Limited | 4.72 Million INR | -1102.519% |
| Gennex Laboratories Limited | 131.75 Million INR | 56.883% |
| TIAAN CONSUMER LIMITED | -23.81 Million INR | 338.585% |
| Vasundhara Rasayans Limited | 58.59 Million INR | 3.048% |
| Parnax Lab Limited | 96.09 Million INR | 40.883% |
| Trinity League India Limited | -27.07 Million INR | 309.844% |
| Sandu Pharmaceuticals Limited | 14.61 Million INR | -288.77% |
| Tyche Industries Limited | 122.42 Million INR | 53.599% |
| Kwality Pharmaceuticals Limited | 237.96 Million INR | 76.128% |
| Transchem Limited | 42.03 Million INR | -35.145% |
| Pharmaids Pharmaceuticals Limited | -79.68 Million INR | 171.294% |
| Panchsheel Organics Limited | 141.07 Million INR | 59.733% |
| Coral Laboratories Limited | 157.89 Million INR | 64.021% |
| KOBO BIOTECH LIMITED | -49.28 Million INR | 215.255% |
| Natural Capsules Limited | 55.53 Million INR | -2.29% |
| Auro Laboratories Limited | 77.92 Million INR | 27.097% |